Terapia Génica del Cáncer
TGC
Shaare Zedek Medical Center
Jerusalén, IsraelPublicaciones en colaboración con investigadores/as de Shaare Zedek Medical Center (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731